Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Wear and Tear: A Breakdown of Degenerative Comorbid Conditions

With the workforce growing older, degenerative conditions may have growing impact on claims
Winter 2025/2026

Creeping Costs: The Rise of Mega Claims in Workers’ Compensation

A small percentage of claims are driving the majority of costs in workers’ comp. What are these “mega claims” and how can we mitigate them?
Winter 2025/2026

Current State of Complex Claims in Workers’ Comp

Statistics from recent studies across the industry shed light on complex claims in workers' compensation.
Winter 2025/2026

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

New Osteoporosis Biosimilar Approved

Enoby™ (denosumab-qdbe) injections are a biosimilar of Prolia®, to help increase bone mass in those with high risk of fracture.
Oct 2025

The Injured Worker Patient in 3D: Driving More Personalized Care Through Strategic Formulary Design

With an effective formulary strategy, PBMs can ensure injured worker patients receive the most appropriate care and create better outcomes.
Oct 2025

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.
Oct 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Cannabis Drug Beats Opioids in Phase 3 Low Back Pain Trial

VER-01, a cannabis extract, outperformed both placebo and opioids in two late-stage clinical trials.
Oct 2025

CWCI Study Finds Poor Performance Across Functional Restoration Programs

Claims in FRPs cost 59% more, likely tied to a gap between guideline recommendations and how FRPs are managed.
Oct 2025

New Study Links Frequent Gabapentin Use to Higher Risk for Cognitive Impairment

Patients who had six or more gabapentin prescriptions were 85% more likely to experience mild cognitive impairment, and 29% were at higher risk for dementia.
Aug 2025
1 2 3 28
lockmap-markermagnifiercrossmenucross-circle